MCAZ approves the use of Johnson and Johnson

Harare Bureau

The Medicines Control Authority of Zimbabwe has approved the use of the single-dose Johnson and Johnson Covid-19 vaccine in the country.

The vaccine becomes the fifth to be approved for use in the country after the Chinese Sinopharm and Sinovac, the Russian Sputnik V and the Indian Covaxin.

“Based on the review of the submitted quality, safety and efficacy data and upon performing a benefit-risk assessment thereof, emergency use authorisation has been granted for Ad26.Sars-Cov-S manufactured by Johnson and Johnson. This authorisation was issued on the basis of section 75 of the Medicines and Allied Substances Control Act (Chapter 15:03),” said the MCAZ.

Related Posts

Scientific collaborations across borders key in addressing health challenges

Robin Muchetu, [email protected] Scientific collaboration across countries, institutions and disciplines has been identified as essential in building a healthier and safer future for all, and single governments cannot do it alone.…

Zimbabwe, Zambia not tourism competitors but co-opetitors: ZTA

Nqobile Bhebhe [email protected] Zimbabwe and Zambia are not tourism competitors but “co-opetitors” whose success lies in collaboration, joint destination marketing and shared regional growth, Zimbabwe Tourism Authority (ZTA) Chief Executive…

Leave a Reply

Your email address will not be published. Required fields are marked *

×
×